Media Alert: American College of Cardiology to host Sports Cardiology Conference
ACC Care of the Athletic Heart highlights latest advances in the field of sports cardiology
2023-06-02
(Press-News.org) The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10, 2023, in Washington, including poster abstracts and educational sessions. The course is designed for all clinicians who provide cardiovascular care for the professional, occupational, tactical or recreational athlete. As the athletic population expands to all demographic groups, it is critical that there is a larger contingent of clinicians who understand the latest care and practice management for athletes at every level.
Dermot Phelan, BAO, MBBCh, PhD, FACC, and Megan Wasfy, MD, FACC, will serve as the course chair and vice chair respectively. The course, which will be available both in-person and online, will feature top sports cardiology experts discussing the latest advances in sports cardiology, as well as fundamental cardiovascular diagnostic and management strategies and treatment options in the field.
Can’t Miss Sessions:
Keynote: Can the Heart Get a Sports Injury?
Participation Screening: The Debate Continues
Debate Topics:
Are We Really Still Having This Debate? ECG vs. No ECG for Preparticipation Screening of Young Competitive Athletes
I’m 50 and I’ve Decided to Run a Marathon – Should I Undergo Preparticipation Screening for Coronary Disease?
Strategies for Engaging the Community in CPR and AED Training
Legal and Ethical Considerations for Shared Decision Making for Sporting Participation in an Athlete with Cardiac Disease
From the Ocean to the Mountain Top – Environmental Considerations for the Athlete with Heart Disease
Posters
The following abstract titles are a selection of posters being presented during the conference. All ACC Care of the Athletic Heart posters and clinical case challenges are embargoed until Thursday, June 8, 2023, at 12 p.m. ET.
Who Performs Cardiopulmonary Resuscitation During Sports-Related Sudden Cardiac Arrest in Athletes?
Return to Play Evaluation Post COVID – Longitudinal Experience in Cardiac Risk Assessment at a Division I Athletic Program
Outcomes and Results of 10 Years of Cardiac Screening of Elite New Zealand Athletes
Cardiovascular Screening of Tactical Athletes: Results from ECG Screening of Cadets and Midshipmen at Military Service Academies
COACH Study: COVID-19 Influence on Athletic Cardiopulmonary Health Assessed as the Change in VO2max: a Systematic Review and Meta-Analysis
If members of the media would like to receive embargoed copies of these abstracts or register for media access to the conference, contact ACC Associate Director for Media Relations Katie Glenn at kglenn@acc.org.
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-02
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years. The authors caution that these benefits must be weighed against risk of toxicity, but, overall, the study shows promising results that warrant larger studies and efforts to identify patients most likely to benefit from this treatment. Their findings are published in Nature Medicine and presented simultaneously at the 2023 ASCO Annual Meeting on June 2.
“There ...
2023-06-02
The paper, published April 17 in The Lancet Regional Health – Americas, was co-authored by Dr. Gunisha Kaur, an associate professor of anesthesiology at Weill Cornell Medicine and medical director of the Weill Cornell Center for Human Rights; Stephen Yale-Loehr, a professor of immigration law practice at Cornell Law School; and Jin K. Park, a medical student at the Harvard School of Medicine and the first DACA recipient awarded a Rhodes Scholarship.
“The erratic enforcement of the DACA program since its inception has led many immigrants and their families to disengage completely from the healthcare system to avoid risking deportation,” said ...
2023-06-02
Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients. A separate $306,000 NIH Small Business Innovation Research grant supports early testing of a compound developed at UofL as a potential treatment.
The three grants combined total $6.1 million.
During the pandemic, health care providers worked tirelessly to treat patients ...
2023-06-02
WASHINGTON --- Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins. When MPNs progress, they can become deadly leukemias.
The findings will be presented at the American Society of Clinical Oncology 2023 annual meeting in Chicago in June.
Agent Orange is an herbicide that was utilized by the United States military ...
2023-06-02
The US Food and Drug Administration (FDA) mandated folic acid fortification of all enriched cereal grains in 1996, and this regulation resulted in a reduction of neural tube defect (NTD)–affected pregnancies for the population in the United States. While this mandatory food fortification strategy is an example of a public health success, Hispanic women in the US continued to be twice as likely to give birth to a child affected by NTD compared to non-Hispanic women. It was not until the year 2016 that the FDA approved voluntary, but not mandatory, folic acid fortification for corn masa flour products in the US to focus on the Hispanic diet staples, such ...
2023-06-02
Usually, the two characterizations of a material are mutually exclusive: something is either stiff, or it can absorb vibrations well – but rarely both. However, if we could make materials that are both stiff and good at absorbing vibrations, there would be a whole host of potential applications, from design at the nano-scale to aerospace engineering.
Buckling does the trick
A team of researchers from the University of Amsterdam has now found a way to create materials that are stiff, but still good at absorbing vibrations – and equally importantly, that can be kept very light-weight. David Dykstra, lead author of the ...
2023-06-02
NEW YORK, N.Y. — June 2. Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis. Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, will help Novartis Pharmaceuticals Corporation (Novartis) conduct the trials through the Lupus Clinical Investigators Network (LuCIN) at top academic centers throughout North America.
Lupus is a devastating heterogeneous autoimmune disease affecting millions worldwide with symptoms that can range from debilitating fatigue to ...
2023-06-02
About The Study: In this randomized crossover trial of autistic children, using a sensory-adapted dental environment was safe and efficacious in decreasing physiological and behavioral distress during dental care. This is important because enhancing oral care is critical for autistic children; this intervention may also be beneficial for populations beyond autism.
Authors: Leah I. Stein Duker, Ph.D., O.T.R./L., of the University of Southern California in Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website ...
2023-06-02
About The Study: This qualitative study found that participants perceived widespread and increasing use of algorithms in health care and lack of oversight, potentially exacerbating racial and ethnic inequities. Increasing awareness for clinicians and patients and standardized, transparent approaches for algorithm development and implementation may be needed to address racial and ethnic biases related to algorithms.
Authors: Peter Treitler, M.S.W., of Rutgers University in New Brunswick, New Jersey, is the corresponding author.
To ...
2023-06-02
Contrary to expectations, the risk for relapses, overdoses and deaths related to substance use disorder didn’t increase after a large-scale prison release in New Jersey, according to a Rutgers study.
The study, published in JAMA Health Forum, examined whether post-release overdose deaths and drug-related hospital and emergency department visits increased after more than 2,000 individuals were released from prison in late 2020 as the result of a pandemic-era policy.
“Risk of relapse and adverse health events is high following prison release, with risk of fatal overdose ...
LAST 30 PRESS RELEASES:
[Press-News.org] Media Alert: American College of Cardiology to host Sports Cardiology Conference
ACC Care of the Athletic Heart highlights latest advances in the field of sports cardiology
